Specific Biologics
Business Services · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
661 University Ave West Towern Ste 1300,...Website
www.specificbiologics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Specific Biologics
Specific Biologics Inc. is a biotechnology company on a mission to develop novel gene editing technologies to treat diseases through precision gene editing. The company's two-site Dualase platform gene editors cut DNA in a way that optimally exploits the cell's naturally occurring DNA repair pathways. This enables two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of Dualase-based therapeutics in areas of high unmet medical need.Explore more
Specific Biologics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Specific Biologics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Specific Biologics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Specific Biologics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Specific Biologics has new funding data
Product Launch: Get notified when Specific Biologics launches new products
Congratulate Masked Content for being promoted to Masked Content at Specific Biologics
Website visits: Recent activity has been detected on your website
Check out if Specific Biologics is spiking on competitors!
Check if Specific Biologics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Specific Biologics recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Specific Biologics
Compare insights from companies similar to Specific Biologics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Specific Biologics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Specific Biologics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Specific Biologics.
Specific Biologics Tech Stack
A closer look at the technologies used by Specific Biologics
Specific Biologics News & Media
Genome Canada and Ontario Genomics Award Specific Biologics and Western University $1.8 Million Grant to Develop a Machine Learning Platform to Accelerate the Development of the Company's Dualase®-based Therapeutics
Funding will expand the range of Dualase® genome editors for new high morbidity and mortality genetic disease targets. TORONTO, March 18, 2026 /PRNewswire/ - Specific Biologics Inc. ("Specific"), a biotechnology company developing industry-leading in vivo genome editing medicines to treat...Specific Biologics Welcomes Accomplished Biotechnology Leader Dr. Richard Glickman to its Board of Directors
TORONTO, Dec. 16, 2025 /PRNewswire/ - Specific Biologics Inc. ("Specific Biologics"), a precision in vivo genome editing company developing highly predictable, efficient and specific Dualase® genome editors to treat the untreatable, today announced the appointment of Dr. Richard Glickman...Specific Biologics Welcomes Paul J. Hastings as Chair of the Board of Directors
TORONTO, June 11, 2025 /PRNewswire/ - Specific Biologics Inc., a biotechnology company advancing Dualase® genome editors for precise and programmable in vivo genome editing, today announced the appointment of Paul J. Hastings as Chair of its Board of Directors. Mr. Hastings is a...Specific Biologics Receives Additional Investment
Specific Biologics, a Toronto, Canada-based early-stage biotechnology company, received an additional investment from Lumira Ventures and adMare BioInnovations. The amount of the deal was not disclosed. In conjunction with the investment, Specific Biologics has appointed Steven Kanner, PhD, as an Independent Director. Dr. Kanner joins Brent Stead, PhD, MBA, as well as seasoned company builders Daniel Hétu, […] The post Specific Biologics Receives Additional Investment appeared first on FinSMEs.
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Specific Biologics
Sign Up For FreeTo access detailed company insights
Specific Biologics Inc. is a biotechnology company on a mission to develop novel gene editing technologies to treat diseases through precision gene editing. The company's two-site Dualase platform gene editors cut DNA in a way that optimally exploits the cell's naturally occurring DNA repair pathways. This enables two gene editing outcomes, precise... Read More
